Policy | April 09, 2021
Pharma sector has both brainpower and manpower to drive growth: Mandaviya
The government has taken all the effective measures to make healthcare affordable
The government has taken all the effective measures to make healthcare affordable
Tiger can no longer make an important biotin intermediate using a DSM patented process.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
With cost optimization leading to cumulative savings of US $80 million over last 8 years, the company now aims to tap bigger opportunities in generics business
The company is expecting tremendous growth and a better quarterly performance
Viruses evolve into new strains when there is a change to their genetic composition.
The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside
At the latest Indian Pharma Post E-Conference, leading experts highlighted the need for accredited trial sites, skilled investigators, digital ecosystems, and greater public trust
The proposed changes seek to shorten the statutory timelines for granting manufacturing licences across various risk categories
The transition of the existing Anemia Mukt Bharat programme into Anemia Mukt Bharat Abhiyaan signals a shift towards a more comprehensive, technology-enabled and community-driven approach
Subscribe To Our Newsletter & Stay Updated
